VANCOUVER, British Columbia--(BUSINESS WIRE)--Dr. John Todd, president and CEO of ProtoKinetix, Inc. (OTCBB:PKTX), announces today the results of a series of tests conducted by ITTEC Stem laboratory in Montreal. These results confirm that AAGP™ reduces inflammation.
